Bridgewater, NJ, United States of America

Yang Cao

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yang Cao. Retrieved from https://idiyas.com/inventor/yang-cao-j5cv1izu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yang Cao

Introduction

Yang Cao is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for assessing the efficacy of specific inhibitors.

Latest Patents

Yang Cao holds a patent titled "Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase." This patent provides innovative techniques for evaluating the potency, specificity, and toxicity of inhibitors targeting microsomal prostaglandin E2 synthase, utilizing a unique cell-based assay system. He has 1 patent to his name.

Career Highlights

Cao is currently employed at Aventis Pharmaceuticals Inc., where he continues to advance research in the pharmaceutical industry. His work has been instrumental in developing new therapeutic strategies.

Collaborations

Yang Cao has collaborated with notable colleagues, including Stephen Ayers and Jeffrey Stephen Sabol, contributing to a dynamic research environment.

Conclusion

Yang Cao's innovative work in the pharmaceutical sector exemplifies the impact of dedicated inventors on healthcare advancements. His contributions continue to shape the future of drug development and efficacy assessment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…